Product Images Pramipexole Dihydrochloride

This is a description of Pramipexole Dihydrochloride Extended-Release Tablets. Each tablet contains 0.375mg of the substance. The tablets must not be chewed, crushed, or divided but swallowed whole as per the accompanying prescribing information. The tablets are to be kept at room temperature between 15°C to 30°C and protected from high humidity. It is manufactured by Alembic Pharmaceuticals Limited, India. The tablets come in an original use container and must be kept away from children. It is a once-daily medication that comes with a patient information leaflet that should be given to each patient by the pharmacist. The Lot number is B0 and the National Drug Code (NDC) is 46708-574-30.*

This is a prescription medication that contains 0.7 mg of pramipexole dihydrochloride monohydrate USP per extended-release tablet. The tablets should be stored at room temperature and protected from high humidity. The dosage instructions specify that tablets must be swallowed whole and not chewed, crushed, or divided. The medication should be kept out of reach of children and dispensed in its original use container. This medication is manufactured by Alembic Pharmaceuticals in India and is available in a pack of 30 tablets. The accompanying patient information leaflet should be dispensed to each patient by the pharmacist. The lot number is BO and the NDC number is 46708-575-30.*

Each tablet of this medication contains 1.5mg of pramipexole dihydrochloride monohydrate USP. It is recommended to store it at room temperature and protect it from exposure to high humidity. The tablets must be swallowed whole and not chewed or divided. It is important to read the accompanying prescription information before taking this medication. This medication should be kept out of reach of children and dispensed in the original unit of use container. The medication is manufactured by Aembic Pharmaceuticals Limited, and it is an extended-release medication to be taken once daily. The pharmacist is instructed to dispense the accompanying patient information leaflet to each patient. Lot number and license number are also present.*

Each extended-release tablet contains 225 mg of pramipexole dihydrochloride monohydrate USP. The tablets should be stored at 25°C (77°F) and protected from exposure to high humidity. The dosage and usage instructions are provided in the accompanying prescribing information. The tablets should be swallowed whole and kept out of reach of children. The tablets are dispensed in the original container and for pharmacist dispensing, an accompanying patient information leaflet should be provided. The manufacturing company is Alembic Pharmaceuticals Limited, located in Gujarat, India. The lot number is BO.*

These are Pramipexole Dihydrochloride Extended Release Tablets. Each tablet contains 3.75 mg of Pramipexole Dihydrochloride Monohydrate USP. The tablets should be stored at 25°C (77°F) and protected from high humidity. It is important not to chew, crush, or divide the tablets, which must be swallowed whole. Keep out of reach of children and dispense from the original unit of use container. The tablets come with an accompanying patient information leaflet. Manufactured by Alembic Pharmaceuticals Limited, these tablets are once daily and the lot number is B0.*

Each tablet of this medication contains 3 mg of Pramipexole Dihydrochloride Monohydrate USP. It is recommended to store at a temperature range of 15 to 30°C and protect from high humidity. The prescription information should be read before consumption, and the tablets should not be chewed, crushed, or divided. This medication must be kept out of children's reach and dispensed in its original container. The manufacturer of this medication is Alembic Pharmaceuticals Limited. The medication is an extended-release tablet that is taken once a day. The package contains 30 tablets, and a pharmacist should dispense it with the patient information leaflet.*

Each tablet of this medication contains 4.5mg of Pramipexole Dihydrochloride, a substance used for treating restless legs syndrome and Parkinson's disease. The recommended storage temperature is between 15° to 30°C and it should be protected from high humidity. The tablets should be ingested as a whole, without being chewed, crushed, or divided. The medicine must be kept out of the reach of children and dispensed in its original unopened container. The medication is manufactured by Alembic Pharmaceuticals and the accompanying leaflet must be given to patients by the pharmacist. The provided lot number is "BO" and the NDC code is 46708-580-30.*